These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
222 related articles for article (PubMed ID: 19808330)
1. The effects of vasodilators in pulmonary hypertension: pulmonary vascular or peripheral vascular? Rich S Circ Heart Fail; 2009 Mar; 2(2):145-50. PubMed ID: 19808330 [No Abstract] [Full Text] [Related]
2. Should patients with pulmonary hypertension and increased pulmonary resistance be treated with vasodilators? Rich S Cardiovasc Clin; 1990; 21(1):265-74; discussion 275-6. PubMed ID: 2199052 [No Abstract] [Full Text] [Related]
3. Effects of sildenafil on pulmonary hypertension and exercise tolerance in severe cystic fibrosis-related lung disease. Montgomery GS; Sagel SD; Taylor AL; Abman SH Pediatr Pulmonol; 2006 Apr; 41(4):383-5. PubMed ID: 16479610 [TBL] [Abstract][Full Text] [Related]
4. [Vasodilators in "primary" pulmonary hypertension?]. Morpurgo M G Ital Cardiol; 1990 Feb; 20(2):123-25. PubMed ID: 2328865 [No Abstract] [Full Text] [Related]
5. [Primary pulmonary hypertension. An overview with special reference to risk-benefit analysis of therapy]. Schilling W Z Erkr Atmungsorgane; 1991; 177(3):117-34. PubMed ID: 1808861 [TBL] [Abstract][Full Text] [Related]
6. Central role of peripheral mechanisms in exercise intolerance in chronic heart failure: the muscle hypothesis. Piepoli M Cardiologia; 1998 Sep; 43(9):909-17. PubMed ID: 9859605 [No Abstract] [Full Text] [Related]
17. Repetitive dosing of intravenous levosimendan improves pulmonary hemodynamics in patients with pulmonary hypertension: results of a pilot study. Kleber FX; Bollmann T; Borst MM; Costard-Jäckle A; Ewert R; Kivikko M; Petterson T; Pohjanjousi P; Sonntag S; Wikström G J Clin Pharmacol; 2009 Jan; 49(1):109-15. PubMed ID: 18981240 [No Abstract] [Full Text] [Related]
18. Therapy of pulmonary hypertension: the evolution from vasodilators to antiproliferative agents. Rubin LJ Am J Respir Crit Care Med; 2002 Nov; 166(10):1308-9. PubMed ID: 12421739 [No Abstract] [Full Text] [Related]
19. [Vasodilator agents in pulmonary hypertension]. Farga V Rev Med Chil; 1987 Sep; 115(9):902-4. PubMed ID: 3506285 [No Abstract] [Full Text] [Related]
20. Vasodilators in patients with chronic obstructive pulmonary disease and pulmonary hypertension: not ready for prime time! Humbert M; Simonneau G Am J Respir Crit Care Med; 2010 Feb; 181(3):202-3. PubMed ID: 20093654 [No Abstract] [Full Text] [Related] [Next] [New Search]